Who we are

At AbbVie, we have the expertise of a proven pharmaceutical leader and the focus and passion of an entrepreneur and innovator. The result is something rare in health care today – a global biopharmaceutical company that has the ability to discover and advance innovative therapies and meet the health needs of people and societies around the globe.

Committed to Patient-Centered Innovation

When it comes to innovating, AbbVie starts with the patient. We draw on our deep expertise in some of the most difficult-to-treat diseases and on our understanding of the patient journey to identify opportunities to create better outcomes at every stage. This patient-centered approach to discovery and development ensures we remain focused on our goal of improving lives.

Committed to Patient-Centered Innovation

FAR REACH AND FOCUS

People today live longer, healthier lives, but along with a longer life expectancy comes a higher prevalence of chronic disease. We take a broad perspective on improving healthcare and are committed to new thinking and approaches; we strive to find new solutions that will enable healthcare systems to bring medical innovation to more patients cost effectively.

FAST FACTS

  • 170+ Countries where our products help patients
  • 28,000 Approximate number of employees committed to patients’ needs
  • MILLIONS Around the world are helped by AbbVie medicines
  • ABBV NYSE stock exchange listing

Download the eu whitepaper